<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00121667</url>
  </required_header>
  <id_info>
    <org_study_id>CV181-014</org_study_id>
    <nct_id>NCT00121667</nct_id>
  </id_info>
  <brief_title>Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone</brief_title>
  <official_title>&quot;A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The purpose of this clinical research study is to learn whether Saxagliptin added to
      Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic
      subjects who are not sufficiently controlled with Metformin alone
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will participate in a lead-in period, and qualifying subjects will continue into
      a short-term randomized treatment period. Subjects who complete the short-term period will be
      eligible to enter the long term extension period. Also, subjects in the short-term period who
      have an elevated blood sugar that requires additional medication for blood sugar control will
      be eligible to enter the long-term treatment extension period where they will receive
      pioglitizone added onto their blinded study medication
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">October 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>Mean change from baseline is adjusted for baseline value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>Mean change from baseline is adjusted for baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>Mean change from baseline is adjusted for baseline value.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Overall Summary of Adverse Events During ST+LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
    <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
  </other_outcome>
  <other_outcome>
    <measure>Marked Laboratory Abnormalities - During ST + LT Treatment Period</measure>
    <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure: 124, 118, 130, 95 weeks, respectively, for 2.5mg, 5mg, 10 mg, placebo.</time_frame>
    <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</measure>
    <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</measure>
    <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Heart Rate During the ST + LT Period</measure>
    <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</measure>
    <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206,</time_frame>
    <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
  </other_outcome>
  <other_outcome>
    <measure>All Reported Hypoglycemic Adverse Events During the ST + LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
    <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
  </other_outcome>
  <other_outcome>
    <measure>Confirmed Hypoglycemia During the ST + LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
    <description>'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1462</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Saxagliptin + Metformin (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pioglitazone 15-45 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saxagliptin + Metformin (B)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pioglitazone 15-45 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saxagliptin + Metformin (C)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pioglitazone 15-45 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo+ Metformin (D)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pioglitazone 15-45 mg (as needed for rescue)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin + Metformin</intervention_name>
    <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Saxagliptin + Metformin (A)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin + Metformin</intervention_name>
    <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Saxagliptin + Metformin (B)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin + Metformin</intervention_name>
    <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Saxagliptin + Metformin (C)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo + Metformin</intervention_name>
    <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Placebo+ Metformin (D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pioglitazone</intervention_name>
    <description>Tablets, Oral, 15 - 45 mg (as needed for rescue)</description>
    <arm_group_label>Saxagliptin + Metformin (A)</arm_group_label>
    <arm_group_label>Saxagliptin + Metformin (B)</arm_group_label>
    <arm_group_label>Saxagliptin + Metformin (C)</arm_group_label>
    <arm_group_label>Placebo+ Metformin (D)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus requiring treatment with at least 1500 mg but not greater
             than 2550 mg of a maximum tolerated dose of Metformin therapy for at least 8 weeks
             prior to screening.

          -  HbA1c &gt;= 7.0% and &lt;= 10.0 %

          -  Body mass index &lt;= 40 kg/m2

          -  Fasting C-peptide &gt;= 1 ng/dL

        Exclusion Criteria:

          -  Symptomatic poorly controlled diabetes

          -  Recent cardiac or cerebrovascular event

          -  Serum creatinine &gt;= 1.5 mg/dL for males and &gt;= 1.4 mg/dL for females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Anniston</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Calera</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Haleyville</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sherwood</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Encino</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Castle Rock</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Altamonte Springs</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Chipley</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Cocoa Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Marianna</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Vernon Hills</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Lafayette</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Munfordville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>West Monroe</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Chester</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Prince Frederick</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Toms River</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sparta</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Athens</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Lyndhurst</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Carlisle</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Levittown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Duncan</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bryan</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Hampton</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Olympia</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mar Del Plata</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Woollongong</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kippa Ring</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Meadowbrook</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Woodville South</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceara</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Belem</city>
        <state>Para</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Porto alegre</city>
        <state>Rio Grande Do Sul</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Marilia</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Brandon</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Portage La Prairie</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bathurst</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mount Pearl</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. Johns</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Aylmer</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Woodstock</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Charlottetown</city>
        <state>Prince Edward Island</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Drummondville</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fleurimont</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. Leonard</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Santiago De Chile</city>
        <state>Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Santiago</city>
        <state>Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Celaya</city>
        <state>Guanajuato</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Morelia</city>
        <state>Michioacan</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Hermosillo</city>
        <state>Sonora</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Merida</city>
        <state>Yucatan</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Distrito Federal</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Durango</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Carolina</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ponce</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Rio Pieoras</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Hualien</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Mexico</country>
    <country>Puerto Rico</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm</description>
  </link>
  <reference>
    <citation>DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS; Saxagliptin 014 Study Group. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care. 2009 Sep;32(9):1649-55. doi: 10.2337/dc08-1984. Epub 2009 May 28.</citation>
    <PMID>19478198</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2005</study_first_submitted>
  <study_first_submitted_qc>July 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <results_first_submitted>March 15, 2011</results_first_submitted>
  <results_first_submitted_qc>March 15, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 8, 2011</results_first_posted>
  <disposition_first_submitted>July 30, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>August 13, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 18, 2010</disposition_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pioglitazone</mesh_term>
    <mesh_term>Saxagliptin</mesh_term>
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1462 participants were enrolled, and 787 entered the lead-in period. 45 discontinued the during the lead-in period. 19 subjects no longer met study criteria, 10 subjects withdrew consent, and 2 subjects were randomized but not treated.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Saxagliptin 2.5 mg + Metformin</title>
          <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="P2">
          <title>Saxagliptin 5 mg + Metformin</title>
          <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="P3">
          <title>Saxagliptin 10 mg + Metformin</title>
          <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="P4">
          <title>Placebo+ Metformin</title>
          <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Short Term (ST) Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="192"/>
                <participants group_id="P2" count="191"/>
                <participants group_id="P3" count="181"/>
                <participants group_id="P4" count="179"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
                <participants group_id="P2" count="143"/>
                <participants group_id="P3" count="140"/>
                <participants group_id="P4" count="112"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="48"/>
                <participants group_id="P3" count="41"/>
                <participants group_id="P4" count="67"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="27"/>
                <participants group_id="P4" count="44"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor / Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject No Longer Meets Study Criteria</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Short Term (ST) + Long Term (LT) Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="192"/>
                <participants group_id="P2" count="191"/>
                <participants group_id="P3" count="181"/>
                <participants group_id="P4" count="179"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Study Without Being Rescued</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="68"/>
                <participants group_id="P4" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="128"/>
                <participants group_id="P2" count="133"/>
                <participants group_id="P3" count="113"/>
                <participants group_id="P4" count="140"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="42"/>
                <participants group_id="P4" count="65"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject No Longer Meets Study Criteria</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor / Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Saxagliptin 2.5 mg + Metformin</title>
          <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="B2">
          <title>Saxagliptin 5 mg + Metformin</title>
          <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="B3">
          <title>Saxagliptin 10 mg + Metformin</title>
          <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="B4">
          <title>Placebo+ Metformin</title>
          <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="192"/>
            <count group_id="B2" value="191"/>
            <count group_id="B3" value="181"/>
            <count group_id="B4" value="179"/>
            <count group_id="B5" value="743"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.66" spread="10.08"/>
                    <measurement group_id="B2" value="54.69" spread="9.62"/>
                    <measurement group_id="B3" value="54.18" spread="10.14"/>
                    <measurement group_id="B4" value="54.76" spread="10.18"/>
                    <measurement group_id="B5" value="54.57" spread="9.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="155"/>
                    <measurement group_id="B4" value="153"/>
                    <measurement group_id="B5" value="626"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="109"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="86"/>
                    <measurement group_id="B4" value="83"/>
                    <measurement group_id="B5" value="366"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="95"/>
                    <measurement group_id="B4" value="96"/>
                    <measurement group_id="B5" value="377"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="144"/>
                    <measurement group_id="B4" value="150"/>
                    <measurement group_id="B5" value="606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black / African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic / Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic / Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="49"/>
                    <measurement group_id="B5" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="98"/>
                    <measurement group_id="B4" value="103"/>
                    <measurement group_id="B5" value="406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age Characterization Female Only</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>=&lt; 50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="62"/>
                    <measurement group_id="B5" value="254"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85.97" spread="17.57"/>
                    <measurement group_id="B2" value="87.26" spread="17.04"/>
                    <measurement group_id="B3" value="87.83" spread="18.90"/>
                    <measurement group_id="B4" value="87.14" spread="17.75"/>
                    <measurement group_id="B5" value="87.04" spread="17.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.68" spread="5.15"/>
                    <measurement group_id="B2" value="31.23" spread="4.67"/>
                    <measurement group_id="B3" value="31.12" spread="4.79"/>
                    <measurement group_id="B4" value="31.57" spread="4.80"/>
                    <measurement group_id="B5" value="31.40" spread="4.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index Categorization</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="84"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="76"/>
                    <measurement group_id="B5" value="317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="99"/>
                    <measurement group_id="B4" value="103"/>
                    <measurement group_id="B5" value="426"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24</title>
        <description>Mean change from baseline is adjusted for baseline value.</description>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized participants with both a baseline and post-baseline value (up to Week 24)</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24</title>
          <description>Mean change from baseline is adjusted for baseline value.</description>
          <population>Randomized participants with both a baseline and post-baseline value (up to Week 24)</population>
          <units>percentage of glycosylated hemoglobins</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="186"/>
                <count group_id="O3" value="180"/>
                <count group_id="O4" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.08" spread="0.07"/>
                    <measurement group_id="O2" value="8.07" spread="0.06"/>
                    <measurement group_id="O3" value="7.98" spread="0.08"/>
                    <measurement group_id="O4" value="8.06" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Mean Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="0.07"/>
                    <measurement group_id="O2" value="-0.69" spread="0.07"/>
                    <measurement group_id="O3" value="-0.58" spread="0.07"/>
                    <measurement group_id="O4" value="0.13" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.73</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.92</ci_lower_limit>
            <ci_upper_limit>-0.53</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.83</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.02</ci_lower_limit>
            <ci_upper_limit>-0.63</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.72</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.91</ci_lower_limit>
            <ci_upper_limit>-0.52</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24</title>
        <description>Mean change from baseline is adjusted for baseline value.</description>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24</title>
          <description>Mean change from baseline is adjusted for baseline value.</description>
          <population>Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="187"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173.57" spread="3.23"/>
                    <measurement group_id="O2" value="179.03" spread="3.44"/>
                    <measurement group_id="O3" value="175.86" spread="3.73"/>
                    <measurement group_id="O4" value="174.94" spread="3.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Mean Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.31" spread="2.48"/>
                    <measurement group_id="O2" value="-22.03" spread="2.49"/>
                    <measurement group_id="O3" value="-20.50" spread="2.53"/>
                    <measurement group_id="O4" value="1.24" spread="2.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-15.55</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.56</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-22.55</ci_lower_limit>
            <ci_upper_limit>-8.55</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-23.28</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.57</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-30.29</ci_lower_limit>
            <ci_upper_limit>-16.27</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-21.74</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.60</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-28.81</ci_lower_limit>
            <ci_upper_limit>-14.68</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</title>
        <time_frame>Week 24</time_frame>
        <population>Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</title>
          <population>Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="186"/>
                <count group_id="O3" value="180"/>
                <count group_id="O4" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.1"/>
                    <measurement group_id="O2" value="43.5"/>
                    <measurement group_id="O3" value="44.4"/>
                    <measurement group_id="O4" value="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>20.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>10.6</ci_lower_limit>
            <ci_upper_limit>30.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>27.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>17.0</ci_lower_limit>
            <ci_upper_limit>36.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>27.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>17.7</ci_lower_limit>
            <ci_upper_limit>37.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</title>
        <description>Mean change from baseline is adjusted for baseline value.</description>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</title>
          <description>Mean change from baseline is adjusted for baseline value.</description>
          <population>Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).</population>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48224" spread="869.70"/>
                    <measurement group_id="O2" value="49021" spread="876.17"/>
                    <measurement group_id="O3" value="44931" spread="889.85"/>
                    <measurement group_id="O4" value="47407" spread="1071.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Mean Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8891" spread="797.97"/>
                    <measurement group_id="O2" value="-9586" spread="810.46"/>
                    <measurement group_id="O3" value="-8137" spread="807.88"/>
                    <measurement group_id="O4" value="-3291" spread="853.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-5599</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1168.2</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7894</ci_lower_limit>
            <ci_upper_limit>-3305</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6294</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1176.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8606</ci_lower_limit>
            <ci_upper_limit>-3983</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4845</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1175.1</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7153</ci_lower_limit>
            <ci_upper_limit>-2537</ci_upper_limit>
            <estimate_desc>ANCOVA model: difference between week t and baseline values = baseline values + treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Overall Summary of Adverse Events During ST+LT Treatment Period</title>
        <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
        <population>All treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Summary of Adverse Events During ST+LT Treatment Period</title>
          <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
          <population>All treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Least 1 AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177"/>
                    <measurement group_id="O2" value="155"/>
                    <measurement group_id="O3" value="161"/>
                    <measurement group_id="O4" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="65"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Marked Laboratory Abnormalities - During ST + LT Treatment Period</title>
        <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
        <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure: 124, 118, 130, 95 weeks, respectively, for 2.5mg, 5mg, 10 mg, placebo.</time_frame>
        <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Marked Laboratory Abnormalities - During ST + LT Treatment Period</title>
          <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
          <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hemoglobin &lt; 8 g/dL (n=189, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematocrit &lt; 0.75 x pre-Rx (n=189, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &lt; 50 x 10^9 c/L (n=189, 188, 181, 178)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &gt; 1.5 x ULN (n=189, 188, 181, 178)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Leukocytes &lt; 2 x 1000 c/µL (n=189, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils+Bands &lt;1x1000 c/µL (n=189,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophils &gt;0.9x1000 c/µL (n=189, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes &lt;=0.75x1000 c/µL (n=189,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;3 x pre-Rx and &gt;ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;1.5 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;3 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;5 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;10 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;20 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;3 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;5 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;10 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;20 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2mg/dL (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;1.5xULN (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2xULN (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN &gt;2 x pre-Rx and &gt;ULN (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine &gt;2.5 mg/dL (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &lt; 50 mg/dL (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &gt; 500 mg/dL (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &lt; 50 mg/dL (n=0,0,0,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &gt; 500 mg/dL (n=0,0,0,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Fasting&lt;50mg/dL(n=189,189,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Fasting&gt;500mg/dL(n=189,189,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Unspec.&lt;50mg/dL(n=192,191,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Unspec.&gt;500mg/dL(n=192,191,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum Low (*) (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum High (*) (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Serum Low (*) (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Serum High (n=190,190,181,179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &lt; 90 mEq/L (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &gt; 120 mEq/L (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin &lt; 0.9 LLN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine Kinase &gt; 5 x ULN (n=190, 190, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric Acid &gt; 1.5 x ULN (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Protein Urine, &gt;=2-4 (n=187, 189, 180, 178)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Urine, &gt;=2-4 (n=187, 189, 180, 178)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Red Blood Cells Urine &gt;=2-4 (n=175,176,162,166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White Blood Cells Urine &gt;=2-4 (n=175,176,162,166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.06" spread="0.098"/>
                    <measurement group_id="O2" value="14.18" spread="0.094"/>
                    <measurement group_id="O3" value="14.18" spread="0.103"/>
                    <measurement group_id="O4" value="13.99" spread="0.096"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=181, 177, 172, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.044"/>
                    <measurement group_id="O2" value="-0.18" spread="0.052"/>
                    <measurement group_id="O3" value="-0.18" spread="0.044"/>
                    <measurement group_id="O4" value="-0.09" spread="0.046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 178, 174, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.052"/>
                    <measurement group_id="O2" value="-0.15" spread="0.047"/>
                    <measurement group_id="O3" value="-0.09" spread="0.053"/>
                    <measurement group_id="O4" value="0.03" spread="0.056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=176, 174, 166, 160)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.052"/>
                    <measurement group_id="O2" value="-0.15" spread="0.050"/>
                    <measurement group_id="O3" value="-0.07" spread="0.050"/>
                    <measurement group_id="O4" value="0.00" spread="0.055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=173, 176, 165, 157)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.058"/>
                    <measurement group_id="O2" value="-0.07" spread="0.051"/>
                    <measurement group_id="O3" value="-0.02" spread="0.055"/>
                    <measurement group_id="O4" value="0.01" spread="0.056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=149, 134, 137, 131)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.061"/>
                    <measurement group_id="O2" value="-0.17" spread="0.057"/>
                    <measurement group_id="O3" value="-0.16" spread="0.067"/>
                    <measurement group_id="O4" value="-0.16" spread="0.064"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 167, 160, 144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.059"/>
                    <measurement group_id="O2" value="-0.11" spread="0.054"/>
                    <measurement group_id="O3" value="0.03" spread="0.055"/>
                    <measurement group_id="O4" value="-0.05" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 154, 146, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.059"/>
                    <measurement group_id="O2" value="-0.20" spread="0.055"/>
                    <measurement group_id="O3" value="-0.10" spread="0.068"/>
                    <measurement group_id="O4" value="-0.02" spread="0.066"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=167, 166, 159, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.059"/>
                    <measurement group_id="O2" value="-0.13" spread="0.052"/>
                    <measurement group_id="O3" value="-0.10" spread="0.060"/>
                    <measurement group_id="O4" value="-0.01" spread="0.060"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 158, 149, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="0.069"/>
                    <measurement group_id="O2" value="-0.28" spread="0.050"/>
                    <measurement group_id="O3" value="-0.19" spread="0.059"/>
                    <measurement group_id="O4" value="-0.09" spread="0.062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.059"/>
                    <measurement group_id="O2" value="-0.23" spread="0.061"/>
                    <measurement group_id="O3" value="-0.10" spread="0.060"/>
                    <measurement group_id="O4" value="-0.12" spread="0.060"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 152, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="0.064"/>
                    <measurement group_id="O2" value="-0.33" spread="0.063"/>
                    <measurement group_id="O3" value="-0.25" spread="0.062"/>
                    <measurement group_id="O4" value="-0.23" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=164, 160, 159, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.064"/>
                    <measurement group_id="O2" value="-0.30" spread="0.063"/>
                    <measurement group_id="O3" value="-0.25" spread="0.057"/>
                    <measurement group_id="O4" value="-0.24" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=161, 155, 154, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="0.059"/>
                    <measurement group_id="O2" value="-0.29" spread="0.063"/>
                    <measurement group_id="O3" value="-0.22" spread="0.071"/>
                    <measurement group_id="O4" value="-0.18" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=152, 149, 146, 122)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.068"/>
                    <measurement group_id="O2" value="-0.29" spread="0.064"/>
                    <measurement group_id="O3" value="-0.19" spread="0.067"/>
                    <measurement group_id="O4" value="-0.17" spread="0.066"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=151, 142, 146, 127)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" spread="0.061"/>
                    <measurement group_id="O2" value="-0.22" spread="0.070"/>
                    <measurement group_id="O3" value="-0.13" spread="0.066"/>
                    <measurement group_id="O4" value="-0.12" spread="0.077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=148, 137, 142, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.068"/>
                    <measurement group_id="O2" value="-0.28" spread="0.096"/>
                    <measurement group_id="O3" value="-0.17" spread="0.067"/>
                    <measurement group_id="O4" value="-0.07" spread="0.073"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.27" spread="0.077"/>
                    <measurement group_id="O2" value="-0.31" spread="0.080"/>
                    <measurement group_id="O3" value="-0.26" spread="0.066"/>
                    <measurement group_id="O4" value="-0.26" spread="0.083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=123, 114, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" spread="0.074"/>
                    <measurement group_id="O2" value="-0.38" spread="0.075"/>
                    <measurement group_id="O3" value="-0.32" spread="0.083"/>
                    <measurement group_id="O4" value="-0.25" spread="0.088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=108, 104, 112, 70)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.073"/>
                    <measurement group_id="O2" value="-0.40" spread="0.085"/>
                    <measurement group_id="O3" value="-0.27" spread="0.078"/>
                    <measurement group_id="O4" value="-0.34" spread="0.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=99, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.26" spread="0.073"/>
                    <measurement group_id="O2" value="-0.26" spread="0.082"/>
                    <measurement group_id="O3" value="-0.36" spread="0.092"/>
                    <measurement group_id="O4" value="-0.26" spread="0.106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=92, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="0.095"/>
                    <measurement group_id="O2" value="-0.41" spread="0.097"/>
                    <measurement group_id="O3" value="-0.39" spread="0.095"/>
                    <measurement group_id="O4" value="-0.28" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 79, 85, 48)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="0.091"/>
                    <measurement group_id="O2" value="-0.45" spread="0.093"/>
                    <measurement group_id="O3" value="-0.42" spread="0.104"/>
                    <measurement group_id="O4" value="-0.45" spread="0.132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=81, 74, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="0.092"/>
                    <measurement group_id="O2" value="-0.56" spread="0.105"/>
                    <measurement group_id="O3" value="-0.47" spread="0.102"/>
                    <measurement group_id="O4" value="-0.57" spread="0.107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=77, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="0.085"/>
                    <measurement group_id="O2" value="-0.58" spread="0.127"/>
                    <measurement group_id="O3" value="-0.53" spread="0.119"/>
                    <measurement group_id="O4" value="-0.51" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=70, 61, 73, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.62" spread="0.099"/>
                    <measurement group_id="O2" value="-0.81" spread="0.154"/>
                    <measurement group_id="O3" value="-0.46" spread="0.107"/>
                    <measurement group_id="O4" value="-0.53" spread="0.129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.60" spread="0.103"/>
                    <measurement group_id="O2" value="-0.82" spread="0.159"/>
                    <measurement group_id="O3" value="-0.47" spread="0.101"/>
                    <measurement group_id="O4" value="-0.53" spread="0.134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 50, 64, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.62" spread="0.108"/>
                    <measurement group_id="O2" value="-0.87" spread="0.135"/>
                    <measurement group_id="O3" value="-0.49" spread="0.101"/>
                    <measurement group_id="O4" value="-0.75" spread="0.125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>percentage red blood cells</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.9" spread="0.26"/>
                    <measurement group_id="O2" value="42.3" spread="0.25"/>
                    <measurement group_id="O3" value="42.2" spread="0.29"/>
                    <measurement group_id="O4" value="41.8" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=181, 177, 172, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.15"/>
                    <measurement group_id="O2" value="-0.5" spread="0.17"/>
                    <measurement group_id="O3" value="-0.5" spread="0.15"/>
                    <measurement group_id="O4" value="-0.4" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 178, 174, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.17"/>
                    <measurement group_id="O2" value="-0.4" spread="0.15"/>
                    <measurement group_id="O3" value="-0.2" spread="0.18"/>
                    <measurement group_id="O4" value="-0.0" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=176, 174, 166, 160)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.17"/>
                    <measurement group_id="O2" value="-0.3" spread="0.17"/>
                    <measurement group_id="O3" value="-0.1" spread="0.18"/>
                    <measurement group_id="O4" value="-0.0" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=173, 176, 165, 157)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.18"/>
                    <measurement group_id="O2" value="-0.1" spread="0.17"/>
                    <measurement group_id="O3" value="-0.0" spread="0.19"/>
                    <measurement group_id="O4" value="-0.0" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=149, 134, 137, 131)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.19"/>
                    <measurement group_id="O2" value="-0.4" spread="0.18"/>
                    <measurement group_id="O3" value="-0.2" spread="0.21"/>
                    <measurement group_id="O4" value="-0.1" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 167, 160, 144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.18"/>
                    <measurement group_id="O2" value="-0.1" spread="0.17"/>
                    <measurement group_id="O3" value="0.4" spread="0.19"/>
                    <measurement group_id="O4" value="0.0" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 154, 146, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.18"/>
                    <measurement group_id="O2" value="-0.2" spread="0.17"/>
                    <measurement group_id="O3" value="-0.1" spread="0.23"/>
                    <measurement group_id="O4" value="0.0" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=167, 166, 159, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.20"/>
                    <measurement group_id="O2" value="0.0" spread="0.18"/>
                    <measurement group_id="O3" value="-0.1" spread="0.21"/>
                    <measurement group_id="O4" value="0.2" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 158, 149, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.21"/>
                    <measurement group_id="O2" value="-0.5" spread="0.17"/>
                    <measurement group_id="O3" value="-0.3" spread="0.18"/>
                    <measurement group_id="O4" value="-0.1" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.19"/>
                    <measurement group_id="O2" value="-0.3" spread="0.19"/>
                    <measurement group_id="O3" value="-0.2" spread="0.20"/>
                    <measurement group_id="O4" value="-0.3" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 152, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.21"/>
                    <measurement group_id="O2" value="-0.5" spread="0.21"/>
                    <measurement group_id="O3" value="-0.5" spread="0.21"/>
                    <measurement group_id="O4" value="-0.5" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=164, 160, 159, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.20"/>
                    <measurement group_id="O2" value="-0.4" spread="0.21"/>
                    <measurement group_id="O3" value="-0.3" spread="0.19"/>
                    <measurement group_id="O4" value="-0.4" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=161, 155, 154, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.19"/>
                    <measurement group_id="O2" value="-0.4" spread="0.23"/>
                    <measurement group_id="O3" value="-0.0" spread="0.21"/>
                    <measurement group_id="O4" value="-0.2" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=152, 149, 146, 122)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.21"/>
                    <measurement group_id="O2" value="-0.4" spread="0.21"/>
                    <measurement group_id="O3" value="0.0" spread="0.23"/>
                    <measurement group_id="O4" value="-0.1" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=151, 142, 146, 127)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.21"/>
                    <measurement group_id="O2" value="-0.5" spread="0.23"/>
                    <measurement group_id="O3" value="-0.1" spread="0.22"/>
                    <measurement group_id="O4" value="-0.0" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=148, 137, 142, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.22"/>
                    <measurement group_id="O2" value="-0.5" spread="0.28"/>
                    <measurement group_id="O3" value="-0.1" spread="0.22"/>
                    <measurement group_id="O4" value="-0.0" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.25"/>
                    <measurement group_id="O2" value="-0.4" spread="0.23"/>
                    <measurement group_id="O3" value="0.1" spread="0.22"/>
                    <measurement group_id="O4" value="-0.4" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=123, 114, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.27"/>
                    <measurement group_id="O2" value="-0.5" spread="0.25"/>
                    <measurement group_id="O3" value="-0.3" spread="0.27"/>
                    <measurement group_id="O4" value="-0.3" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=108, 104, 112, 70)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.21"/>
                    <measurement group_id="O2" value="-0.9" spread="0.29"/>
                    <measurement group_id="O3" value="-0.2" spread="0.25"/>
                    <measurement group_id="O4" value="-0.7" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=99, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.22"/>
                    <measurement group_id="O2" value="0.0" spread="0.29"/>
                    <measurement group_id="O3" value="-0.4" spread="0.28"/>
                    <measurement group_id="O4" value="-0.2" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=92, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.27"/>
                    <measurement group_id="O2" value="-0.5" spread="0.32"/>
                    <measurement group_id="O3" value="-0.5" spread="0.28"/>
                    <measurement group_id="O4" value="-0.5" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 79, 85, 48)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.26"/>
                    <measurement group_id="O2" value="-0.6" spread="0.28"/>
                    <measurement group_id="O3" value="-0.3" spread="0.31"/>
                    <measurement group_id="O4" value="-0.9" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=81, 74, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.28"/>
                    <measurement group_id="O2" value="-1.7" spread="0.30"/>
                    <measurement group_id="O3" value="-1.2" spread="0.32"/>
                    <measurement group_id="O4" value="-1.6" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=77, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="0.26"/>
                    <measurement group_id="O2" value="-1.6" spread="0.34"/>
                    <measurement group_id="O3" value="-1.2" spread="0.36"/>
                    <measurement group_id="O4" value="-1.1" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=70, 61, 73, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="0.32"/>
                    <measurement group_id="O2" value="-1.8" spread="0.46"/>
                    <measurement group_id="O3" value="-0.7" spread="0.30"/>
                    <measurement group_id="O4" value="-1.2" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.33"/>
                    <measurement group_id="O2" value="-1.7" spread="0.46"/>
                    <measurement group_id="O3" value="-0.5" spread="0.33"/>
                    <measurement group_id="O4" value="-0.7" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 50, 64, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.35"/>
                    <measurement group_id="O2" value="-2.3" spread="0.41"/>
                    <measurement group_id="O3" value="-0.7" spread="0.32"/>
                    <measurement group_id="O4" value="-1.3" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^6 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.68" spread="0.031"/>
                    <measurement group_id="O2" value="4.73" spread="0.029"/>
                    <measurement group_id="O3" value="4.70" spread="0.034"/>
                    <measurement group_id="O4" value="4.66" spread="0.033"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=181, 177, 172, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.015"/>
                    <measurement group_id="O2" value="-0.05" spread="0.016"/>
                    <measurement group_id="O3" value="-0.05" spread="0.015"/>
                    <measurement group_id="O4" value="-0.03" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 178, 174, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.018"/>
                    <measurement group_id="O2" value="-0.04" spread="0.016"/>
                    <measurement group_id="O3" value="-0.01" spread="0.019"/>
                    <measurement group_id="O4" value="0.01" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=176, 174, 166, 160)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.017"/>
                    <measurement group_id="O2" value="-0.02" spread="0.016"/>
                    <measurement group_id="O3" value="0.00" spread="0.018"/>
                    <measurement group_id="O4" value="0.03" spread="0.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=173, 176, 165, 157)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.019"/>
                    <measurement group_id="O2" value="0.02" spread="0.017"/>
                    <measurement group_id="O3" value="0.03" spread="0.019"/>
                    <measurement group_id="O4" value="0.03" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=149, 134, 137, 131)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.020"/>
                    <measurement group_id="O2" value="-0.02" spread="0.019"/>
                    <measurement group_id="O3" value="0.00" spread="0.021"/>
                    <measurement group_id="O4" value="0.00" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 167, 160, 144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.019"/>
                    <measurement group_id="O2" value="0.03" spread="0.018"/>
                    <measurement group_id="O3" value="0.09" spread="0.020"/>
                    <measurement group_id="O4" value="0.04" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 154, 146, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.019"/>
                    <measurement group_id="O2" value="0.01" spread="0.018"/>
                    <measurement group_id="O3" value="0.04" spread="0.024"/>
                    <measurement group_id="O4" value="0.04" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=167, 166, 159, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.020"/>
                    <measurement group_id="O2" value="0.05" spread="0.017"/>
                    <measurement group_id="O3" value="0.07" spread="0.021"/>
                    <measurement group_id="O4" value="0.08" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 158, 149, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.024"/>
                    <measurement group_id="O2" value="-0.01" spread="0.018"/>
                    <measurement group_id="O3" value="0.04" spread="0.018"/>
                    <measurement group_id="O4" value="0.03" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.020"/>
                    <measurement group_id="O2" value="0.02" spread="0.020"/>
                    <measurement group_id="O3" value="0.06" spread="0.020"/>
                    <measurement group_id="O4" value="0.03" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 152, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.022"/>
                    <measurement group_id="O2" value="-0.03" spread="0.020"/>
                    <measurement group_id="O3" value="0.01" spread="0.020"/>
                    <measurement group_id="O4" value="-0.02" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=164, 160, 159, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.022"/>
                    <measurement group_id="O2" value="-0.02" spread="0.020"/>
                    <measurement group_id="O3" value="0.01" spread="0.019"/>
                    <measurement group_id="O4" value="-0.03" spread="0.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=161, 155, 154, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.020"/>
                    <measurement group_id="O2" value="-0.02" spread="0.021"/>
                    <measurement group_id="O3" value="0.02" spread="0.022"/>
                    <measurement group_id="O4" value="-0.01" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=152, 149, 146, 122)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.023"/>
                    <measurement group_id="O2" value="-0.01" spread="0.019"/>
                    <measurement group_id="O3" value="0.02" spread="0.021"/>
                    <measurement group_id="O4" value="0.00" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=151, 142, 146, 127)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.022"/>
                    <measurement group_id="O2" value="-0.04" spread="0.023"/>
                    <measurement group_id="O3" value="0.00" spread="0.021"/>
                    <measurement group_id="O4" value="-0.03" spread="0.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=148, 137, 142, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.022"/>
                    <measurement group_id="O2" value="-0.04" spread="0.031"/>
                    <measurement group_id="O3" value="-0.01" spread="0.023"/>
                    <measurement group_id="O4" value="-0.02" spread="0.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.025"/>
                    <measurement group_id="O2" value="-0.06" spread="0.024"/>
                    <measurement group_id="O3" value="-0.02" spread="0.023"/>
                    <measurement group_id="O4" value="-0.09" spread="0.029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=123, 114, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.027"/>
                    <measurement group_id="O2" value="-0.09" spread="0.024"/>
                    <measurement group_id="O3" value="-0.07" spread="0.030"/>
                    <measurement group_id="O4" value="-0.07" spread="0.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=108, 104, 112, 70)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.024"/>
                    <measurement group_id="O2" value="-0.12" spread="0.027"/>
                    <measurement group_id="O3" value="-0.07" spread="0.027"/>
                    <measurement group_id="O4" value="-0.14" spread="0.031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=99, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.024"/>
                    <measurement group_id="O2" value="-0.04" spread="0.026"/>
                    <measurement group_id="O3" value="-0.06" spread="0.027"/>
                    <measurement group_id="O4" value="-0.11" spread="0.034"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=92, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.028"/>
                    <measurement group_id="O2" value="-0.07" spread="0.030"/>
                    <measurement group_id="O3" value="-0.06" spread="0.027"/>
                    <measurement group_id="O4" value="-0.08" spread="0.031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 79, 85, 48)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.030"/>
                    <measurement group_id="O2" value="-0.10" spread="0.027"/>
                    <measurement group_id="O3" value="-0.06" spread="0.031"/>
                    <measurement group_id="O4" value="-0.13" spread="0.041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=81, 74, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="0.032"/>
                    <measurement group_id="O2" value="-0.17" spread="0.029"/>
                    <measurement group_id="O3" value="-0.11" spread="0.029"/>
                    <measurement group_id="O4" value="-0.20" spread="0.035"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=77, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.030"/>
                    <measurement group_id="O2" value="-0.15" spread="0.032"/>
                    <measurement group_id="O3" value="-0.12" spread="0.034"/>
                    <measurement group_id="O4" value="-0.16" spread="0.041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=70, 61, 73, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.033"/>
                    <measurement group_id="O2" value="-0.21" spread="0.038"/>
                    <measurement group_id="O3" value="-0.09" spread="0.033"/>
                    <measurement group_id="O4" value="-0.16" spread="0.037"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.035"/>
                    <measurement group_id="O2" value="-0.22" spread="0.040"/>
                    <measurement group_id="O3" value="-0.12" spread="0.032"/>
                    <measurement group_id="O4" value="-0.13" spread="0.044"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 50, 64, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.040"/>
                    <measurement group_id="O2" value="-0.25" spread="0.044"/>
                    <measurement group_id="O3" value="-0.09" spread="0.032"/>
                    <measurement group_id="O4" value="-0.15" spread="0.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^9 c/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 189, 181, 178)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="265.5" spread="4.78"/>
                    <measurement group_id="O2" value="256.2" spread="4.28"/>
                    <measurement group_id="O3" value="258.7" spread="5.05"/>
                    <measurement group_id="O4" value="261.0" spread="5.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=179, 168, 167, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="2.32"/>
                    <measurement group_id="O2" value="9.8" spread="2.77"/>
                    <measurement group_id="O3" value="6.5" spread="2.57"/>
                    <measurement group_id="O4" value="13.7" spread="2.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 172, 168, 164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="2.59"/>
                    <measurement group_id="O2" value="11.8" spread="2.55"/>
                    <measurement group_id="O3" value="5.1" spread="2.31"/>
                    <measurement group_id="O4" value="11.1" spread="3.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=171, 171, 164, 157)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="2.46"/>
                    <measurement group_id="O2" value="8.5" spread="2.78"/>
                    <measurement group_id="O3" value="5.1" spread="4.16"/>
                    <measurement group_id="O4" value="12.0" spread="2.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 170, 162, 151)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="2.53"/>
                    <measurement group_id="O2" value="7.5" spread="2.47"/>
                    <measurement group_id="O3" value="4.9" spread="2.67"/>
                    <measurement group_id="O4" value="8.5" spread="3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=147, 132, 137, 129)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="2.73"/>
                    <measurement group_id="O2" value="8.5" spread="3.23"/>
                    <measurement group_id="O3" value="0.5" spread="3.24"/>
                    <measurement group_id="O4" value="11.5" spread="3.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 165, 157, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="2.49"/>
                    <measurement group_id="O2" value="9.3" spread="3.26"/>
                    <measurement group_id="O3" value="4.8" spread="3.24"/>
                    <measurement group_id="O4" value="8.2" spread="2.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=153, 149, 145, 133)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="3.16"/>
                    <measurement group_id="O2" value="7.4" spread="2.70"/>
                    <measurement group_id="O3" value="2.5" spread="3.08"/>
                    <measurement group_id="O4" value="7.5" spread="2.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 161, 156, 133)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="2.71"/>
                    <measurement group_id="O2" value="7.1" spread="2.76"/>
                    <measurement group_id="O3" value="-0.0" spread="2.64"/>
                    <measurement group_id="O4" value="7.4" spread="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=152, 155, 147, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="2.95"/>
                    <measurement group_id="O2" value="3.0" spread="2.66"/>
                    <measurement group_id="O3" value="5.2" spread="2.82"/>
                    <measurement group_id="O4" value="8.5" spread="3.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=160, 151, 153, 144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="3.00"/>
                    <measurement group_id="O2" value="7.0" spread="3.07"/>
                    <measurement group_id="O3" value="-1.7" spread="2.64"/>
                    <measurement group_id="O4" value="6.8" spread="3.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=151, 148, 142, 134)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="2.50"/>
                    <measurement group_id="O2" value="9.7" spread="2.98"/>
                    <measurement group_id="O3" value="-1.7" spread="2.95"/>
                    <measurement group_id="O4" value="4.1" spread="3.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=158, 153, 156, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="2.97"/>
                    <measurement group_id="O2" value="3.5" spread="2.77"/>
                    <measurement group_id="O3" value="-2.0" spread="2.75"/>
                    <measurement group_id="O4" value="-2.3" spread="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=157, 153, 148, 130)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="2.96"/>
                    <measurement group_id="O2" value="3.6" spread="2.88"/>
                    <measurement group_id="O3" value="-0.8" spread="3.18"/>
                    <measurement group_id="O4" value="2.0" spread="3.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=149, 142, 139, 120)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="3.07"/>
                    <measurement group_id="O2" value="-4.1" spread="3.16"/>
                    <measurement group_id="O3" value="-11.9" spread="2.98"/>
                    <measurement group_id="O4" value="-2.3" spread="3.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=151, 141, 143, 120)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="3.40"/>
                    <measurement group_id="O2" value="-2.4" spread="3.44"/>
                    <measurement group_id="O3" value="-9.0" spread="3.13"/>
                    <measurement group_id="O4" value="-6.4" spread="3.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 132, 137, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="3.24"/>
                    <measurement group_id="O2" value="3.5" spread="3.36"/>
                    <measurement group_id="O3" value="0.1" spread="4.80"/>
                    <measurement group_id="O4" value="-4.7" spread="4.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=132, 124, 130, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="3.84"/>
                    <measurement group_id="O2" value="4.0" spread="3.55"/>
                    <measurement group_id="O3" value="-2.6" spread="3.09"/>
                    <measurement group_id="O4" value="4.7" spread="3.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 111, 122, 84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="4.42"/>
                    <measurement group_id="O2" value="8.6" spread="3.01"/>
                    <measurement group_id="O3" value="1.4" spread="3.68"/>
                    <measurement group_id="O4" value="13.6" spread="3.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=107, 103, 110, 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="3.96"/>
                    <measurement group_id="O2" value="6.1" spread="3.47"/>
                    <measurement group_id="O3" value="3.3" spread="3.74"/>
                    <measurement group_id="O4" value="6.1" spread="5.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=99, 93, 98, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="4.45"/>
                    <measurement group_id="O2" value="4.2" spread="4.12"/>
                    <measurement group_id="O3" value="1.2" spread="4.19"/>
                    <measurement group_id="O4" value="7.0" spread="5.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=91, 84, 88, 51)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="5.27"/>
                    <measurement group_id="O2" value="3.2" spread="3.89"/>
                    <measurement group_id="O3" value="2.2" spread="4.41"/>
                    <measurement group_id="O4" value="4.5" spread="4.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=83, 77, 84, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="4.96"/>
                    <measurement group_id="O2" value="6.5" spread="4.45"/>
                    <measurement group_id="O3" value="1.1" spread="5.21"/>
                    <measurement group_id="O4" value="12.0" spread="5.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=79, 70, 77, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="5.65"/>
                    <measurement group_id="O2" value="9.4" spread="4.55"/>
                    <measurement group_id="O3" value="-1.8" spread="5.79"/>
                    <measurement group_id="O4" value="12.5" spread="7.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=75, 64, 74, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="5.39"/>
                    <measurement group_id="O2" value="3.2" spread="4.39"/>
                    <measurement group_id="O3" value="-1.9" spread="5.26"/>
                    <measurement group_id="O4" value="13.8" spread="6.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=68, 60, 71, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="6.19"/>
                    <measurement group_id="O2" value="-1.2" spread="5.65"/>
                    <measurement group_id="O3" value="-8.3" spread="5.07"/>
                    <measurement group_id="O4" value="8.9" spread="5.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=67, 57, 68, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="6.40"/>
                    <measurement group_id="O2" value="-2.9" spread="5.40"/>
                    <measurement group_id="O3" value="-8.5" spread="5.19"/>
                    <measurement group_id="O4" value="12.2" spread="6.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 49, 64, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="6.45"/>
                    <measurement group_id="O2" value="1.5" spread="7.48"/>
                    <measurement group_id="O3" value="-4.7" spread="5.62"/>
                    <measurement group_id="O4" value="9.8" spread="7.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.23" spread="0.136"/>
                    <measurement group_id="O2" value="7.25" spread="0.167"/>
                    <measurement group_id="O3" value="7.12" spread="0.136"/>
                    <measurement group_id="O4" value="7.19" spread="0.136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 171, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.093"/>
                    <measurement group_id="O2" value="-0.03" spread="0.116"/>
                    <measurement group_id="O3" value="0.17" spread="0.102"/>
                    <measurement group_id="O4" value="0.11" spread="0.113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 176, 171, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.111"/>
                    <measurement group_id="O2" value="0.04" spread="0.131"/>
                    <measurement group_id="O3" value="-0.02" spread="0.100"/>
                    <measurement group_id="O4" value="0.22" spread="0.117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.089"/>
                    <measurement group_id="O2" value="0.02" spread="0.102"/>
                    <measurement group_id="O3" value="0.07" spread="0.092"/>
                    <measurement group_id="O4" value="0.07" spread="0.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 174, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.104"/>
                    <measurement group_id="O2" value="-0.03" spread="0.116"/>
                    <measurement group_id="O3" value="0.19" spread="0.106"/>
                    <measurement group_id="O4" value="0.03" spread="0.109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="0.108"/>
                    <measurement group_id="O2" value="0.37" spread="0.126"/>
                    <measurement group_id="O3" value="0.23" spread="0.105"/>
                    <measurement group_id="O4" value="0.39" spread="0.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=169, 166, 159, 142)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.100"/>
                    <measurement group_id="O2" value="0.08" spread="0.134"/>
                    <measurement group_id="O3" value="0.26" spread="0.114"/>
                    <measurement group_id="O4" value="0.37" spread="0.130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" spread="0.142"/>
                    <measurement group_id="O2" value="0.30" spread="0.148"/>
                    <measurement group_id="O3" value="0.24" spread="0.121"/>
                    <measurement group_id="O4" value="0.33" spread="0.132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 159, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.103"/>
                    <measurement group_id="O2" value="0.07" spread="0.127"/>
                    <measurement group_id="O3" value="0.16" spread="0.115"/>
                    <measurement group_id="O4" value="0.42" spread="0.139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 158, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="0.121"/>
                    <measurement group_id="O2" value="0.23" spread="0.135"/>
                    <measurement group_id="O3" value="0.39" spread="0.114"/>
                    <measurement group_id="O4" value="0.58" spread="0.135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.112"/>
                    <measurement group_id="O2" value="-0.02" spread="0.130"/>
                    <measurement group_id="O3" value="0.19" spread="0.111"/>
                    <measurement group_id="O4" value="0.39" spread="0.142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 152, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" spread="0.112"/>
                    <measurement group_id="O2" value="0.36" spread="0.138"/>
                    <measurement group_id="O3" value="0.24" spread="0.112"/>
                    <measurement group_id="O4" value="0.50" spread="0.120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.103"/>
                    <measurement group_id="O2" value="0.12" spread="0.161"/>
                    <measurement group_id="O3" value="0.11" spread="0.097"/>
                    <measurement group_id="O4" value="0.10" spread="0.135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=160, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.091"/>
                    <measurement group_id="O2" value="0.05" spread="0.131"/>
                    <measurement group_id="O3" value="0.21" spread="0.109"/>
                    <measurement group_id="O4" value="0.14" spread="0.141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.130"/>
                    <measurement group_id="O2" value="0.10" spread="0.137"/>
                    <measurement group_id="O3" value="0.02" spread="0.105"/>
                    <measurement group_id="O4" value="0.10" spread="0.135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 125)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.116"/>
                    <measurement group_id="O2" value="-0.14" spread="0.160"/>
                    <measurement group_id="O3" value="-0.20" spread="0.114"/>
                    <measurement group_id="O4" value="-0.36" spread="0.120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.117"/>
                    <measurement group_id="O2" value="-0.10" spread="0.123"/>
                    <measurement group_id="O3" value="-0.02" spread="0.168"/>
                    <measurement group_id="O4" value="-0.39" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="0.122"/>
                    <measurement group_id="O2" value="-0.18" spread="0.157"/>
                    <measurement group_id="O3" value="-0.25" spread="0.105"/>
                    <measurement group_id="O4" value="-0.30" spread="0.172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 114, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.29" spread="0.141"/>
                    <measurement group_id="O2" value="-0.34" spread="0.136"/>
                    <measurement group_id="O3" value="-0.21" spread="0.153"/>
                    <measurement group_id="O4" value="-0.38" spread="0.197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=105, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.140"/>
                    <measurement group_id="O2" value="-0.11" spread="0.150"/>
                    <measurement group_id="O3" value="-0.31" spread="0.102"/>
                    <measurement group_id="O4" value="-0.54" spread="0.178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.142"/>
                    <measurement group_id="O2" value="-0.26" spread="0.161"/>
                    <measurement group_id="O3" value="-0.05" spread="0.183"/>
                    <measurement group_id="O4" value="-0.15" spread="0.202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=90, 87, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.162"/>
                    <measurement group_id="O2" value="-0.27" spread="0.148"/>
                    <measurement group_id="O3" value="-0.12" spread="0.155"/>
                    <measurement group_id="O4" value="-0.32" spread="0.225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 85, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.156"/>
                    <measurement group_id="O2" value="-0.42" spread="0.161"/>
                    <measurement group_id="O3" value="0.13" spread="0.174"/>
                    <measurement group_id="O4" value="-0.07" spread="0.235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=77, 72, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="0.170"/>
                    <measurement group_id="O2" value="-0.38" spread="0.226"/>
                    <measurement group_id="O3" value="-0.55" spread="0.144"/>
                    <measurement group_id="O4" value="-0.54" spread="0.180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=76, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.179"/>
                    <measurement group_id="O2" value="-0.18" spread="0.178"/>
                    <measurement group_id="O3" value="-0.18" spread="0.152"/>
                    <measurement group_id="O4" value="-0.38" spread="0.177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=70, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="0.185"/>
                    <measurement group_id="O2" value="-0.72" spread="0.212"/>
                    <measurement group_id="O3" value="-0.38" spread="0.142"/>
                    <measurement group_id="O4" value="-0.37" spread="0.190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.45" spread="0.160"/>
                    <measurement group_id="O2" value="-0.34" spread="0.228"/>
                    <measurement group_id="O3" value="-0.13" spread="0.143"/>
                    <measurement group_id="O4" value="-0.35" spread="0.203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 49, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.58" spread="0.175"/>
                    <measurement group_id="O2" value="-0.80" spread="0.270"/>
                    <measurement group_id="O3" value="-0.36" spread="0.170"/>
                    <measurement group_id="O4" value="-0.71" spread="0.201"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.27" spread="0.101"/>
                    <measurement group_id="O2" value="4.27" spread="0.127"/>
                    <measurement group_id="O3" value="4.19" spread="0.105"/>
                    <measurement group_id="O4" value="4.23" spread="0.102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 170, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.083"/>
                    <measurement group_id="O2" value="0.05" spread="0.102"/>
                    <measurement group_id="O3" value="0.21" spread="0.087"/>
                    <measurement group_id="O4" value="0.12" spread="0.094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 175, 170, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.097"/>
                    <measurement group_id="O2" value="0.11" spread="0.116"/>
                    <measurement group_id="O3" value="0.15" spread="0.090"/>
                    <measurement group_id="O4" value="0.19" spread="0.098"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.075"/>
                    <measurement group_id="O2" value="0.10" spread="0.093"/>
                    <measurement group_id="O3" value="0.22" spread="0.085"/>
                    <measurement group_id="O4" value="0.07" spread="0.098"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 172, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.087"/>
                    <measurement group_id="O2" value="0.03" spread="0.103"/>
                    <measurement group_id="O3" value="0.35" spread="0.096"/>
                    <measurement group_id="O4" value="0.02" spread="0.097"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.094"/>
                    <measurement group_id="O2" value="0.28" spread="0.106"/>
                    <measurement group_id="O3" value="0.26" spread="0.093"/>
                    <measurement group_id="O4" value="0.19" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=168, 166, 159, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.085"/>
                    <measurement group_id="O2" value="0.11" spread="0.110"/>
                    <measurement group_id="O3" value="0.40" spread="0.102"/>
                    <measurement group_id="O4" value="0.27" spread="0.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" spread="0.123"/>
                    <measurement group_id="O2" value="0.24" spread="0.125"/>
                    <measurement group_id="O3" value="0.32" spread="0.109"/>
                    <measurement group_id="O4" value="0.17" spread="0.112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 157, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.093"/>
                    <measurement group_id="O2" value="0.14" spread="0.113"/>
                    <measurement group_id="O3" value="0.30" spread="0.107"/>
                    <measurement group_id="O4" value="0.33" spread="0.113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 157, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="0.104"/>
                    <measurement group_id="O2" value="0.16" spread="0.116"/>
                    <measurement group_id="O3" value="0.41" spread="0.099"/>
                    <measurement group_id="O4" value="0.34" spread="0.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.096"/>
                    <measurement group_id="O2" value="0.06" spread="0.109"/>
                    <measurement group_id="O3" value="0.32" spread="0.099"/>
                    <measurement group_id="O4" value="0.24" spread="0.122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 151, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.096"/>
                    <measurement group_id="O2" value="0.24" spread="0.116"/>
                    <measurement group_id="O3" value="0.30" spread="0.097"/>
                    <measurement group_id="O4" value="0.24" spread="0.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.088"/>
                    <measurement group_id="O2" value="0.15" spread="0.150"/>
                    <measurement group_id="O3" value="0.20" spread="0.091"/>
                    <measurement group_id="O4" value="0.03" spread="0.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=159, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.085"/>
                    <measurement group_id="O2" value="0.03" spread="0.117"/>
                    <measurement group_id="O3" value="0.26" spread="0.090"/>
                    <measurement group_id="O4" value="0.04" spread="0.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.110"/>
                    <measurement group_id="O2" value="0.11" spread="0.122"/>
                    <measurement group_id="O3" value="0.20" spread="0.096"/>
                    <measurement group_id="O4" value="0.08" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 124)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.104"/>
                    <measurement group_id="O2" value="0.02" spread="0.144"/>
                    <measurement group_id="O3" value="-0.01" spread="0.107"/>
                    <measurement group_id="O4" value="-0.25" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.107"/>
                    <measurement group_id="O2" value="0.03" spread="0.100"/>
                    <measurement group_id="O3" value="0.23" spread="0.140"/>
                    <measurement group_id="O4" value="-0.25" spread="0.119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.108"/>
                    <measurement group_id="O2" value="0.02" spread="0.133"/>
                    <measurement group_id="O3" value="0.03" spread="0.101"/>
                    <measurement group_id="O4" value="-0.13" spread="0.146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 113, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.121"/>
                    <measurement group_id="O2" value="-0.08" spread="0.106"/>
                    <measurement group_id="O3" value="0.08" spread="0.132"/>
                    <measurement group_id="O4" value="-0.18" spread="0.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=104, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.123"/>
                    <measurement group_id="O2" value="-0.04" spread="0.119"/>
                    <measurement group_id="O3" value="-0.05" spread="0.093"/>
                    <measurement group_id="O4" value="-0.35" spread="0.142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.113"/>
                    <measurement group_id="O2" value="-0.13" spread="0.145"/>
                    <measurement group_id="O3" value="0.11" spread="0.167"/>
                    <measurement group_id="O4" value="-0.01" spread="0.169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=90, 87, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.147"/>
                    <measurement group_id="O2" value="-0.04" spread="0.111"/>
                    <measurement group_id="O3" value="0.11" spread="0.136"/>
                    <measurement group_id="O4" value="-0.11" spread="0.185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 84, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.128"/>
                    <measurement group_id="O2" value="-0.23" spread="0.131"/>
                    <measurement group_id="O3" value="0.32" spread="0.151"/>
                    <measurement group_id="O4" value="0.07" spread="0.195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=77, 71, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.167"/>
                    <measurement group_id="O2" value="-0.10" spread="0.194"/>
                    <measurement group_id="O3" value="-0.23" spread="0.117"/>
                    <measurement group_id="O4" value="-0.34" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=76, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.161"/>
                    <measurement group_id="O2" value="0.02" spread="0.160"/>
                    <measurement group_id="O3" value="0.06" spread="0.130"/>
                    <measurement group_id="O4" value="-0.22" spread="0.145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=69, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.159"/>
                    <measurement group_id="O2" value="-0.35" spread="0.176"/>
                    <measurement group_id="O3" value="-0.17" spread="0.114"/>
                    <measurement group_id="O4" value="-0.20" spread="0.155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 71, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.25" spread="0.139"/>
                    <measurement group_id="O2" value="-0.11" spread="0.178"/>
                    <measurement group_id="O3" value="0.11" spread="0.118"/>
                    <measurement group_id="O4" value="-0.19" spread="0.185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 48, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.146"/>
                    <measurement group_id="O2" value="-0.40" spread="0.215"/>
                    <measurement group_id="O3" value="-0.03" spread="0.124"/>
                    <measurement group_id="O4" value="-0.29" spread="0.154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.29" spread="0.051"/>
                    <measurement group_id="O2" value="2.29" spread="0.057"/>
                    <measurement group_id="O3" value="2.23" spread="0.051"/>
                    <measurement group_id="O4" value="2.31" spread="0.054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 170, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.037"/>
                    <measurement group_id="O2" value="-0.07" spread="0.036"/>
                    <measurement group_id="O3" value="-0.03" spread="0.038"/>
                    <measurement group_id="O4" value="-0.02" spread="0.038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 175, 170, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.035"/>
                    <measurement group_id="O2" value="-0.04" spread="0.037"/>
                    <measurement group_id="O3" value="-0.13" spread="0.035"/>
                    <measurement group_id="O4" value="0.00" spread="0.037"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.040"/>
                    <measurement group_id="O2" value="-0.06" spread="0.033"/>
                    <measurement group_id="O3" value="-0.12" spread="0.037"/>
                    <measurement group_id="O4" value="-0.03" spread="0.038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 172, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.038"/>
                    <measurement group_id="O2" value="-0.04" spread="0.039"/>
                    <measurement group_id="O3" value="-0.13" spread="0.038"/>
                    <measurement group_id="O4" value="0.00" spread="0.044"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.046"/>
                    <measurement group_id="O2" value="0.07" spread="0.049"/>
                    <measurement group_id="O3" value="-0.03" spread="0.051"/>
                    <measurement group_id="O4" value="0.15" spread="0.046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=168, 166, 159, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.041"/>
                    <measurement group_id="O2" value="-0.02" spread="0.044"/>
                    <measurement group_id="O3" value="-0.11" spread="0.043"/>
                    <measurement group_id="O4" value="0.07" spread="0.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.045"/>
                    <measurement group_id="O2" value="0.04" spread="0.039"/>
                    <measurement group_id="O3" value="-0.08" spread="0.044"/>
                    <measurement group_id="O4" value="0.11" spread="0.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 157, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.045"/>
                    <measurement group_id="O2" value="-0.08" spread="0.038"/>
                    <measurement group_id="O3" value="-0.12" spread="0.047"/>
                    <measurement group_id="O4" value="0.04" spread="0.051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 157, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.049"/>
                    <measurement group_id="O2" value="0.04" spread="0.044"/>
                    <measurement group_id="O3" value="-0.06" spread="0.048"/>
                    <measurement group_id="O4" value="0.14" spread="0.050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.040"/>
                    <measurement group_id="O2" value="-0.07" spread="0.043"/>
                    <measurement group_id="O3" value="-0.12" spread="0.039"/>
                    <measurement group_id="O4" value="0.10" spread="0.052"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 151, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.044"/>
                    <measurement group_id="O2" value="0.05" spread="0.043"/>
                    <measurement group_id="O3" value="-0.09" spread="0.044"/>
                    <measurement group_id="O4" value="0.18" spread="0.047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.045"/>
                    <measurement group_id="O2" value="-0.02" spread="0.041"/>
                    <measurement group_id="O3" value="-0.09" spread="0.039"/>
                    <measurement group_id="O4" value="0.02" spread="0.051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=159, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.040"/>
                    <measurement group_id="O2" value="0.03" spread="0.045"/>
                    <measurement group_id="O3" value="-0.07" spread="0.048"/>
                    <measurement group_id="O4" value="0.04" spread="0.051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.045"/>
                    <measurement group_id="O2" value="0.00" spread="0.041"/>
                    <measurement group_id="O3" value="-0.17" spread="0.048"/>
                    <measurement group_id="O4" value="0.00" spread="0.051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 124)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.038"/>
                    <measurement group_id="O2" value="-0.17" spread="0.040"/>
                    <measurement group_id="O3" value="-0.25" spread="0.044"/>
                    <measurement group_id="O4" value="-0.10" spread="0.042"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.042"/>
                    <measurement group_id="O2" value="-0.17" spread="0.043"/>
                    <measurement group_id="O3" value="-0.30" spread="0.042"/>
                    <measurement group_id="O4" value="-0.16" spread="0.051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.047"/>
                    <measurement group_id="O2" value="-0.23" spread="0.044"/>
                    <measurement group_id="O3" value="-0.30" spread="0.046"/>
                    <measurement group_id="O4" value="-0.17" spread="0.054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 114, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.053"/>
                    <measurement group_id="O2" value="-0.23" spread="0.062"/>
                    <measurement group_id="O3" value="-0.33" spread="0.047"/>
                    <measurement group_id="O4" value="-0.21" spread="0.061"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=104, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.050"/>
                    <measurement group_id="O2" value="-0.14" spread="0.058"/>
                    <measurement group_id="O3" value="-0.30" spread="0.044"/>
                    <measurement group_id="O4" value="-0.20" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.057"/>
                    <measurement group_id="O2" value="-0.15" spread="0.056"/>
                    <measurement group_id="O3" value="-0.23" spread="0.057"/>
                    <measurement group_id="O4" value="-0.12" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=91, 88, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.061"/>
                    <measurement group_id="O2" value="-0.24" spread="0.057"/>
                    <measurement group_id="O3" value="-0.28" spread="0.053"/>
                    <measurement group_id="O4" value="-0.21" spread="0.075"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 84, 48)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.067"/>
                    <measurement group_id="O2" value="-0.20" spread="0.058"/>
                    <measurement group_id="O3" value="-0.22" spread="0.060"/>
                    <measurement group_id="O4" value="-0.17" spread="0.080"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=78, 71, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.058"/>
                    <measurement group_id="O2" value="-0.28" spread="0.079"/>
                    <measurement group_id="O3" value="-0.35" spread="0.075"/>
                    <measurement group_id="O4" value="-0.19" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=77, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.065"/>
                    <measurement group_id="O2" value="-0.25" spread="0.081"/>
                    <measurement group_id="O3" value="-0.24" spread="0.058"/>
                    <measurement group_id="O4" value="-0.13" spread="0.072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=69, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="0.059"/>
                    <measurement group_id="O2" value="-0.35" spread="0.072"/>
                    <measurement group_id="O3" value="-0.26" spread="0.074"/>
                    <measurement group_id="O4" value="-0.14" spread="0.081"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 71, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="0.069"/>
                    <measurement group_id="O2" value="-0.31" spread="0.081"/>
                    <measurement group_id="O3" value="-0.30" spread="0.071"/>
                    <measurement group_id="O4" value="-0.14" spread="0.079"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 48, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="0.070"/>
                    <measurement group_id="O2" value="-0.39" spread="0.085"/>
                    <measurement group_id="O3" value="-0.36" spread="0.067"/>
                    <measurement group_id="O4" value="-0.32" spread="0.077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.015"/>
                    <measurement group_id="O2" value="0.41" spread="0.015"/>
                    <measurement group_id="O3" value="0.42" spread="0.014"/>
                    <measurement group_id="O4" value="0.40" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 170, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.015"/>
                    <measurement group_id="O2" value="-0.01" spread="0.012"/>
                    <measurement group_id="O3" value="-0.00" spread="0.011"/>
                    <measurement group_id="O4" value="0.01" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 175, 170, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.014"/>
                    <measurement group_id="O2" value="-0.01" spread="0.014"/>
                    <measurement group_id="O3" value="-0.01" spread="0.013"/>
                    <measurement group_id="O4" value="0.03" spread="0.012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.013"/>
                    <measurement group_id="O2" value="-0.01" spread="0.013"/>
                    <measurement group_id="O3" value="0.01" spread="0.011"/>
                    <measurement group_id="O4" value="0.02" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 172, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.016"/>
                    <measurement group_id="O2" value="-0.00" spread="0.013"/>
                    <measurement group_id="O3" value="-0.02" spread="0.012"/>
                    <measurement group_id="O4" value="0.01" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.016"/>
                    <measurement group_id="O2" value="0.02" spread="0.015"/>
                    <measurement group_id="O3" value="0.03" spread="0.012"/>
                    <measurement group_id="O4" value="0.05" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=168, 166, 159, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.011"/>
                    <measurement group_id="O2" value="0.01" spread="0.013"/>
                    <measurement group_id="O3" value="0.01" spread="0.012"/>
                    <measurement group_id="O4" value="0.03" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.015"/>
                    <measurement group_id="O2" value="0.03" spread="0.015"/>
                    <measurement group_id="O3" value="0.03" spread="0.014"/>
                    <measurement group_id="O4" value="0.05" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 157, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.015"/>
                    <measurement group_id="O2" value="0.02" spread="0.014"/>
                    <measurement group_id="O3" value="0.02" spread="0.012"/>
                    <measurement group_id="O4" value="0.03" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 157, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.015"/>
                    <measurement group_id="O2" value="0.04" spread="0.016"/>
                    <measurement group_id="O3" value="0.05" spread="0.014"/>
                    <measurement group_id="O4" value="0.06" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.014"/>
                    <measurement group_id="O2" value="0.02" spread="0.014"/>
                    <measurement group_id="O3" value="0.02" spread="0.011"/>
                    <measurement group_id="O4" value="0.04" spread="0.012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 151, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.015"/>
                    <measurement group_id="O2" value="0.04" spread="0.015"/>
                    <measurement group_id="O3" value="0.03" spread="0.012"/>
                    <measurement group_id="O4" value="0.07" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.015"/>
                    <measurement group_id="O2" value="0.02" spread="0.015"/>
                    <measurement group_id="O3" value="0.02" spread="0.012"/>
                    <measurement group_id="O4" value="0.04" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=159, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.013"/>
                    <measurement group_id="O2" value="0.02" spread="0.015"/>
                    <measurement group_id="O3" value="0.02" spread="0.011"/>
                    <measurement group_id="O4" value="0.05" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.015"/>
                    <measurement group_id="O2" value="0.03" spread="0.017"/>
                    <measurement group_id="O3" value="0.02" spread="0.011"/>
                    <measurement group_id="O4" value="0.03" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 124)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.014"/>
                    <measurement group_id="O2" value="0.04" spread="0.014"/>
                    <measurement group_id="O3" value="0.04" spread="0.011"/>
                    <measurement group_id="O4" value="0.03" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.014"/>
                    <measurement group_id="O2" value="0.06" spread="0.016"/>
                    <measurement group_id="O3" value="0.06" spread="0.019"/>
                    <measurement group_id="O4" value="0.04" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.015"/>
                    <measurement group_id="O2" value="0.05" spread="0.017"/>
                    <measurement group_id="O3" value="0.04" spread="0.012"/>
                    <measurement group_id="O4" value="0.05" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 113, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.018"/>
                    <measurement group_id="O2" value="0.04" spread="0.019"/>
                    <measurement group_id="O3" value="0.06" spread="0.016"/>
                    <measurement group_id="O4" value="0.06" spread="0.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=104, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.018"/>
                    <measurement group_id="O2" value="0.07" spread="0.023"/>
                    <measurement group_id="O3" value="0.03" spread="0.015"/>
                    <measurement group_id="O4" value="0.06" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.018"/>
                    <measurement group_id="O2" value="0.05" spread="0.023"/>
                    <measurement group_id="O3" value="0.08" spread="0.017"/>
                    <measurement group_id="O4" value="0.04" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=90, 87, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.021"/>
                    <measurement group_id="O2" value="0.05" spread="0.024"/>
                    <measurement group_id="O3" value="0.04" spread="0.014"/>
                    <measurement group_id="O4" value="0.04" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 84, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.021"/>
                    <measurement group_id="O2" value="0.06" spread="0.021"/>
                    <measurement group_id="O3" value="0.07" spread="0.018"/>
                    <measurement group_id="O4" value="0.07" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=77, 71, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.021"/>
                    <measurement group_id="O2" value="0.07" spread="0.025"/>
                    <measurement group_id="O3" value="0.03" spread="0.019"/>
                    <measurement group_id="O4" value="0.05" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=76, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.024"/>
                    <measurement group_id="O2" value="0.07" spread="0.024"/>
                    <measurement group_id="O3" value="0.03" spread="0.017"/>
                    <measurement group_id="O4" value="0.05" spread="0.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=69, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.024"/>
                    <measurement group_id="O2" value="0.04" spread="0.024"/>
                    <measurement group_id="O3" value="0.06" spread="0.017"/>
                    <measurement group_id="O4" value="0.04" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 71, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.024"/>
                    <measurement group_id="O2" value="0.08" spread="0.027"/>
                    <measurement group_id="O3" value="0.06" spread="0.017"/>
                    <measurement group_id="O4" value="0.04" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 48, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.018"/>
                    <measurement group_id="O2" value="0.04" spread="0.021"/>
                    <measurement group_id="O3" value="0.02" spread="0.019"/>
                    <measurement group_id="O4" value="0.01" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.003"/>
                    <measurement group_id="O2" value="0.02" spread="0.003"/>
                    <measurement group_id="O3" value="0.02" spread="0.003"/>
                    <measurement group_id="O4" value="0.02" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 170, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.002"/>
                    <measurement group_id="O2" value="-0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 175, 170, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.004"/>
                    <measurement group_id="O4" value="-0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.00" spread="0.003"/>
                    <measurement group_id="O3" value="-0.00" spread="0.003"/>
                    <measurement group_id="O4" value="0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 172, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.00" spread="0.003"/>
                    <measurement group_id="O3" value="-0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=168, 166, 159, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.00" spread="0.004"/>
                    <measurement group_id="O3" value="-0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.01" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.003"/>
                    <measurement group_id="O2" value="0.00" spread="0.003"/>
                    <measurement group_id="O3" value="-0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.01" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 157, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.003"/>
                    <measurement group_id="O2" value="0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 157, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.00" spread="0.004"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.01" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 151, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="0.00" spread="0.004"/>
                    <measurement group_id="O3" value="-0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=159, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.00" spread="0.004"/>
                    <measurement group_id="O4" value="0.00" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="0.00" spread="0.003"/>
                    <measurement group_id="O3" value="0.01" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 124)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.003"/>
                    <measurement group_id="O2" value="0.01" spread="0.004"/>
                    <measurement group_id="O3" value="0.01" spread="0.003"/>
                    <measurement group_id="O4" value="0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.004"/>
                    <measurement group_id="O3" value="0.01" spread="0.005"/>
                    <measurement group_id="O4" value="0.00" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.004"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 113, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.004"/>
                    <measurement group_id="O3" value="0.01" spread="0.003"/>
                    <measurement group_id="O4" value="0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=104, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.005"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="-0.00" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="0.01" spread="0.004"/>
                    <measurement group_id="O4" value="0.00" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=90, 87, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.005"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="-0.00" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 84, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.004"/>
                    <measurement group_id="O3" value="0.01" spread="0.003"/>
                    <measurement group_id="O4" value="-0.01" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=77, 71, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.005"/>
                    <measurement group_id="O3" value="0.00" spread="0.005"/>
                    <measurement group_id="O4" value="-0.01" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=76, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="0.01" spread="0.005"/>
                    <measurement group_id="O4" value="-0.00" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=69, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.005"/>
                    <measurement group_id="O2" value="-0.00" spread="0.006"/>
                    <measurement group_id="O3" value="0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.01" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 71, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.006"/>
                    <measurement group_id="O2" value="0.00" spread="0.006"/>
                    <measurement group_id="O3" value="0.00" spread="0.004"/>
                    <measurement group_id="O4" value="-0.01" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 48, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="0.01" spread="0.005"/>
                    <measurement group_id="O4" value="-0.01" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week 0) (n=192, 191, 181, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.018"/>
                    <measurement group_id="O2" value="0.23" spread="0.016"/>
                    <measurement group_id="O3" value="0.24" spread="0.024"/>
                    <measurement group_id="O4" value="0.21" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=178, 175, 170, 169)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.014"/>
                    <measurement group_id="O2" value="0.01" spread="0.010"/>
                    <measurement group_id="O3" value="-0.00" spread="0.013"/>
                    <measurement group_id="O4" value="0.00" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=176, 175, 170, 166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.023"/>
                    <measurement group_id="O2" value="-0.01" spread="0.011"/>
                    <measurement group_id="O3" value="-0.02" spread="0.016"/>
                    <measurement group_id="O4" value="0.00" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=175, 172, 165, 158)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.017"/>
                    <measurement group_id="O2" value="-0.01" spread="0.012"/>
                    <measurement group_id="O3" value="-0.03" spread="0.012"/>
                    <measurement group_id="O4" value="0.01" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=172, 172, 163, 153)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.019"/>
                    <measurement group_id="O2" value="-0.01" spread="0.011"/>
                    <measurement group_id="O3" value="-0.02" spread="0.011"/>
                    <measurement group_id="O4" value="0.00" spread="0.010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=148, 130, 137, 128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.012"/>
                    <measurement group_id="O2" value="-0.01" spread="0.019"/>
                    <measurement group_id="O3" value="-0.02" spread="0.015"/>
                    <measurement group_id="O4" value="0.01" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=168, 166, 159, 141)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.019"/>
                    <measurement group_id="O2" value="-0.01" spread="0.013"/>
                    <measurement group_id="O3" value="-0.03" spread="0.013"/>
                    <measurement group_id="O4" value="0.00" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=156, 152, 145, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.022"/>
                    <measurement group_id="O2" value="-0.01" spread="0.014"/>
                    <measurement group_id="O3" value="-0.02" spread="0.016"/>
                    <measurement group_id="O4" value="0.02" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 166, 157, 137)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.023"/>
                    <measurement group_id="O2" value="0.00" spread="0.012"/>
                    <measurement group_id="O3" value="-0.02" spread="0.014"/>
                    <measurement group_id="O4" value="0.04" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=155, 157, 149, 139)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.015"/>
                    <measurement group_id="O2" value="-0.00" spread="0.017"/>
                    <measurement group_id="O3" value="-0.00" spread="0.013"/>
                    <measurement group_id="O4" value="0.04" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=162, 153, 154, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.016"/>
                    <measurement group_id="O2" value="-0.01" spread="0.014"/>
                    <measurement group_id="O3" value="-0.02" spread="0.021"/>
                    <measurement group_id="O4" value="0.02" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=157, 151, 143, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.017"/>
                    <measurement group_id="O2" value="-0.00" spread="0.016"/>
                    <measurement group_id="O3" value="0.00" spread="0.011"/>
                    <measurement group_id="O4" value="0.03" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=162, 160, 157, 135)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.022"/>
                    <measurement group_id="O2" value="-0.01" spread="0.021"/>
                    <measurement group_id="O3" value="-0.01" spread="0.013"/>
                    <measurement group_id="O4" value="0.01" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=159, 155, 154, 136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.017"/>
                    <measurement group_id="O2" value="-0.01" spread="0.018"/>
                    <measurement group_id="O3" value="0.00" spread="0.012"/>
                    <measurement group_id="O4" value="0.00" spread="0.012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=150, 149, 146, 121)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.037"/>
                    <measurement group_id="O2" value="-0.02" spread="0.016"/>
                    <measurement group_id="O3" value="-0.03" spread="0.011"/>
                    <measurement group_id="O4" value="-0.01" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=150, 142, 145, 124)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.021"/>
                    <measurement group_id="O2" value="-0.02" spread="0.017"/>
                    <measurement group_id="O3" value="0.02" spread="0.030"/>
                    <measurement group_id="O4" value="-0.02" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=147, 136, 140, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.026"/>
                    <measurement group_id="O2" value="-0.02" spread="0.018"/>
                    <measurement group_id="O3" value="-0.01" spread="0.018"/>
                    <measurement group_id="O4" value="-0.01" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 130, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.031"/>
                    <measurement group_id="O2" value="-0.01" spread="0.020"/>
                    <measurement group_id="O3" value="-0.01" spread="0.014"/>
                    <measurement group_id="O4" value="-0.03" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=122, 113, 123, 85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.028"/>
                    <measurement group_id="O2" value="-0.05" spread="0.023"/>
                    <measurement group_id="O3" value="-0.01" spread="0.018"/>
                    <measurement group_id="O4" value="-0.03" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=104, 104, 111, 68)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.052"/>
                    <measurement group_id="O2" value="0.00" spread="0.018"/>
                    <measurement group_id="O3" value="0.01" spread="0.015"/>
                    <measurement group_id="O4" value="-0.03" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=98, 92, 95, 57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.049"/>
                    <measurement group_id="O2" value="-0.02" spread="0.025"/>
                    <measurement group_id="O3" value="0.00" spread="0.013"/>
                    <measurement group_id="O4" value="-0.03" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=90, 87, 88, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.051"/>
                    <measurement group_id="O2" value="-0.02" spread="0.027"/>
                    <measurement group_id="O3" value="0.01" spread="0.015"/>
                    <measurement group_id="O4" value="-0.03" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=85, 78, 84, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.032"/>
                    <measurement group_id="O2" value="-0.03" spread="0.024"/>
                    <measurement group_id="O3" value="-0.01" spread="0.015"/>
                    <measurement group_id="O4" value="-0.01" spread="0.032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=77, 71, 78, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.051"/>
                    <measurement group_id="O2" value="-0.02" spread="0.017"/>
                    <measurement group_id="O3" value="-0.00" spread="0.018"/>
                    <measurement group_id="O4" value="-0.03" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=76, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.044"/>
                    <measurement group_id="O2" value="-0.01" spread="0.014"/>
                    <measurement group_id="O3" value="0.00" spread="0.020"/>
                    <measurement group_id="O4" value="-0.05" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=69, 60, 72, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.044"/>
                    <measurement group_id="O2" value="-0.03" spread="0.014"/>
                    <measurement group_id="O3" value="-0.01" spread="0.017"/>
                    <measurement group_id="O4" value="-0.04" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=69, 60, 71, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.020"/>
                    <measurement group_id="O2" value="-0.00" spread="0.021"/>
                    <measurement group_id="O3" value="-0.00" spread="0.023"/>
                    <measurement group_id="O4" value="-0.04" spread="0.025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 48, 63, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.019"/>
                    <measurement group_id="O2" value="-0.03" spread="0.020"/>
                    <measurement group_id="O3" value="0.03" spread="0.031"/>
                    <measurement group_id="O4" value="-0.09" spread="0.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</title>
        <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=182, 181, 176, 170)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="1.0"/>
                    <measurement group_id="O2" value="-2.5" spread="1.0"/>
                    <measurement group_id="O3" value="-1.6" spread="0.9"/>
                    <measurement group_id="O4" value="-3.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 179, 175, 164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.0"/>
                    <measurement group_id="O2" value="-2.3" spread="1.1"/>
                    <measurement group_id="O3" value="-3.3" spread="0.9"/>
                    <measurement group_id="O4" value="-2.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=178, 176, 171, 162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.1"/>
                    <measurement group_id="O2" value="-4.1" spread="1.0"/>
                    <measurement group_id="O3" value="-2.8" spread="1.1"/>
                    <measurement group_id="O4" value="-2.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=175, 176, 170, 152)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="1.1"/>
                    <measurement group_id="O2" value="-4.2" spread="1.1"/>
                    <measurement group_id="O3" value="-4.2" spread="1.1"/>
                    <measurement group_id="O4" value="-3.7" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=116, 108, 101, 101)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="1.4"/>
                    <measurement group_id="O2" value="-3.3" spread="1.2"/>
                    <measurement group_id="O3" value="-2.8" spread="1.4"/>
                    <measurement group_id="O4" value="-6.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 166, 161, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="1.1"/>
                    <measurement group_id="O2" value="-2.8" spread="1.1"/>
                    <measurement group_id="O3" value="-4.3" spread="1.0"/>
                    <measurement group_id="O4" value="-4.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=132, 129, 124, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.3"/>
                    <measurement group_id="O2" value="-2.3" spread="1.1"/>
                    <measurement group_id="O3" value="-3.4" spread="1.1"/>
                    <measurement group_id="O4" value="-2.6" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 164, 156, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="1.1"/>
                    <measurement group_id="O2" value="-3.5" spread="1.1"/>
                    <measurement group_id="O3" value="-4.4" spread="1.0"/>
                    <measurement group_id="O4" value="-2.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=144, 141, 132, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="1.2"/>
                    <measurement group_id="O2" value="-2.2" spread="1.2"/>
                    <measurement group_id="O3" value="-4.2" spread="1.1"/>
                    <measurement group_id="O4" value="-4.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=163, 155, 153, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="1.2"/>
                    <measurement group_id="O2" value="-2.2" spread="1.1"/>
                    <measurement group_id="O3" value="-4.9" spread="1.2"/>
                    <measurement group_id="O4" value="-4.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=146, 140, 136, 126)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.2"/>
                    <measurement group_id="O2" value="-3.1" spread="1.2"/>
                    <measurement group_id="O3" value="-3.1" spread="1.2"/>
                    <measurement group_id="O4" value="-4.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=165, 160, 161, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="1.2"/>
                    <measurement group_id="O2" value="-3.6" spread="1.2"/>
                    <measurement group_id="O3" value="-3.8" spread="1.2"/>
                    <measurement group_id="O4" value="-4.5" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=162, 156, 155, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="1.2"/>
                    <measurement group_id="O2" value="-1.1" spread="1.3"/>
                    <measurement group_id="O3" value="-2.5" spread="1.2"/>
                    <measurement group_id="O4" value="-3.4" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=154, 151, 149, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="1.2"/>
                    <measurement group_id="O2" value="-1.8" spread="1.3"/>
                    <measurement group_id="O3" value="-3.3" spread="1.3"/>
                    <measurement group_id="O4" value="-2.3" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=155, 147, 151, 130)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="1.3"/>
                    <measurement group_id="O2" value="-1.7" spread="1.2"/>
                    <measurement group_id="O3" value="-1.9" spread="1.2"/>
                    <measurement group_id="O4" value="-2.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=151, 138, 145, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="1.3"/>
                    <measurement group_id="O2" value="0.9" spread="1.2"/>
                    <measurement group_id="O3" value="-0.6" spread="1.3"/>
                    <measurement group_id="O4" value="-0.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 133, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.5"/>
                    <measurement group_id="O2" value="-0.6" spread="1.4"/>
                    <measurement group_id="O3" value="-0.7" spread="1.3"/>
                    <measurement group_id="O4" value="-1.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=124, 117, 125, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="1.3"/>
                    <measurement group_id="O2" value="0.3" spread="1.4"/>
                    <measurement group_id="O3" value="-1.7" spread="1.4"/>
                    <measurement group_id="O4" value="0.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=111, 107, 113, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="1.5"/>
                    <measurement group_id="O2" value="0.6" spread="1.5"/>
                    <measurement group_id="O3" value="-2.8" spread="1.4"/>
                    <measurement group_id="O4" value="-2.0" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=100, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.8"/>
                    <measurement group_id="O2" value="2.0" spread="1.8"/>
                    <measurement group_id="O3" value="-1.3" spread="1.6"/>
                    <measurement group_id="O4" value="-2.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=94, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.7"/>
                    <measurement group_id="O2" value="2.9" spread="2.0"/>
                    <measurement group_id="O3" value="1.5" spread="1.7"/>
                    <measurement group_id="O4" value="-2.5" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=87, 82, 85, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.8"/>
                    <measurement group_id="O2" value="2.0" spread="1.6"/>
                    <measurement group_id="O3" value="-1.5" spread="1.7"/>
                    <measurement group_id="O4" value="0.3" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=84, 75, 79, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1.7"/>
                    <measurement group_id="O2" value="-0.0" spread="1.8"/>
                    <measurement group_id="O3" value="1.5" spread="1.8"/>
                    <measurement group_id="O4" value="-2.8" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=78, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="1.7"/>
                    <measurement group_id="O2" value="-0.4" spread="2.1"/>
                    <measurement group_id="O3" value="0.7" spread="1.7"/>
                    <measurement group_id="O4" value="-1.8" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=71, 63, 74, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="2.0"/>
                    <measurement group_id="O2" value="3.1" spread="2.1"/>
                    <measurement group_id="O3" value="3.5" spread="1.7"/>
                    <measurement group_id="O4" value="2.7" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="2.0"/>
                    <measurement group_id="O2" value="0.9" spread="2.3"/>
                    <measurement group_id="O3" value="0.2" spread="1.8"/>
                    <measurement group_id="O4" value="-1.4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 53, 64, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="2.1"/>
                    <measurement group_id="O2" value="2.2" spread="2.3"/>
                    <measurement group_id="O3" value="1.7" spread="1.9"/>
                    <measurement group_id="O4" value="-0.4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</title>
        <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=182, 181, 176, 170)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="0.6"/>
                    <measurement group_id="O2" value="-1.1" spread="0.7"/>
                    <measurement group_id="O3" value="-0.9" spread="0.6"/>
                    <measurement group_id="O4" value="-1.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 179, 175, 164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.7"/>
                    <measurement group_id="O2" value="-0.9" spread="0.7"/>
                    <measurement group_id="O3" value="-1.3" spread="0.6"/>
                    <measurement group_id="O4" value="-1.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=178, 176, 171, 162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.7"/>
                    <measurement group_id="O2" value="-1.6" spread="0.7"/>
                    <measurement group_id="O3" value="-0.5" spread="0.6"/>
                    <measurement group_id="O4" value="-1.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=175, 176, 170, 152)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="0.7"/>
                    <measurement group_id="O2" value="-1.9" spread="0.7"/>
                    <measurement group_id="O3" value="-1.5" spread="0.6"/>
                    <measurement group_id="O4" value="-2.2" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=116, 108, 101, 101)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.8"/>
                    <measurement group_id="O2" value="-0.5" spread="0.8"/>
                    <measurement group_id="O3" value="-1.6" spread="0.8"/>
                    <measurement group_id="O4" value="-3.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 166, 161, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.7"/>
                    <measurement group_id="O2" value="-1.0" spread="0.7"/>
                    <measurement group_id="O3" value="-2.1" spread="0.6"/>
                    <measurement group_id="O4" value="-1.7" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=132, 129, 124, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.8"/>
                    <measurement group_id="O2" value="-0.4" spread="0.7"/>
                    <measurement group_id="O3" value="-2.2" spread="0.7"/>
                    <measurement group_id="O4" value="-2.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 164, 156, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.7"/>
                    <measurement group_id="O2" value="-1.0" spread="0.6"/>
                    <measurement group_id="O3" value="-1.7" spread="0.6"/>
                    <measurement group_id="O4" value="-1.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=144, 141, 132, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.8"/>
                    <measurement group_id="O2" value="-0.7" spread="0.8"/>
                    <measurement group_id="O3" value="-2.3" spread="0.7"/>
                    <measurement group_id="O4" value="-1.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=163, 155, 153, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.7"/>
                    <measurement group_id="O2" value="-1.0" spread="0.7"/>
                    <measurement group_id="O3" value="-2.1" spread="0.7"/>
                    <measurement group_id="O4" value="-1.9" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=146, 140, 136, 126)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.8"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                    <measurement group_id="O3" value="-1.6" spread="0.8"/>
                    <measurement group_id="O4" value="-1.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=165, 160, 161, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.7"/>
                    <measurement group_id="O2" value="-1.3" spread="0.8"/>
                    <measurement group_id="O3" value="-2.5" spread="0.7"/>
                    <measurement group_id="O4" value="-2.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=162, 156, 155, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="0.8"/>
                    <measurement group_id="O2" value="-0.5" spread="0.8"/>
                    <measurement group_id="O3" value="-1.6" spread="0.7"/>
                    <measurement group_id="O4" value="-1.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=154, 151, 149, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="0.7"/>
                    <measurement group_id="O2" value="-1.1" spread="0.8"/>
                    <measurement group_id="O3" value="-1.9" spread="0.8"/>
                    <measurement group_id="O4" value="-1.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=155, 147, 151, 130)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="0.8"/>
                    <measurement group_id="O2" value="-1.7" spread="0.8"/>
                    <measurement group_id="O3" value="-1.5" spread="0.7"/>
                    <measurement group_id="O4" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=151, 138, 145, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.8"/>
                    <measurement group_id="O2" value="-0.3" spread="0.7"/>
                    <measurement group_id="O3" value="-0.9" spread="0.7"/>
                    <measurement group_id="O4" value="-0.7" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 133, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.9"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                    <measurement group_id="O3" value="-1.6" spread="0.8"/>
                    <measurement group_id="O4" value="-1.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=124, 117, 125, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="-0.8" spread="0.8"/>
                    <measurement group_id="O3" value="-1.9" spread="0.8"/>
                    <measurement group_id="O4" value="-2.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=111, 107, 113, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="0.9"/>
                    <measurement group_id="O2" value="-0.4" spread="1.0"/>
                    <measurement group_id="O3" value="-2.3" spread="0.9"/>
                    <measurement group_id="O4" value="-3.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=100, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.0"/>
                    <measurement group_id="O2" value="0.7" spread="1.1"/>
                    <measurement group_id="O3" value="-1.1" spread="1.1"/>
                    <measurement group_id="O4" value="-3.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=94, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="1.1"/>
                    <measurement group_id="O2" value="0.0" spread="1.1"/>
                    <measurement group_id="O3" value="-1.2" spread="1.0"/>
                    <measurement group_id="O4" value="-3.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=87, 82, 85, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.1"/>
                    <measurement group_id="O2" value="0.3" spread="1.1"/>
                    <measurement group_id="O3" value="-3.0" spread="1.1"/>
                    <measurement group_id="O4" value="-2.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=84, 75, 79, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.0"/>
                    <measurement group_id="O2" value="-1.8" spread="1.1"/>
                    <measurement group_id="O3" value="-2.7" spread="1.1"/>
                    <measurement group_id="O4" value="-4.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=78, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.0"/>
                    <measurement group_id="O2" value="-1.4" spread="1.3"/>
                    <measurement group_id="O3" value="-1.6" spread="1.2"/>
                    <measurement group_id="O4" value="-2.0" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=71, 63, 74, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.9"/>
                    <measurement group_id="O2" value="-1.4" spread="1.2"/>
                    <measurement group_id="O3" value="-0.9" spread="1.2"/>
                    <measurement group_id="O4" value="-1.6" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.2"/>
                    <measurement group_id="O2" value="-2.6" spread="1.3"/>
                    <measurement group_id="O3" value="-1.7" spread="1.2"/>
                    <measurement group_id="O4" value="-2.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 53, 64, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.0"/>
                    <measurement group_id="O2" value="-0.6" spread="1.4"/>
                    <measurement group_id="O3" value="-2.3" spread="1.3"/>
                    <measurement group_id="O4" value="-2.8" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Heart Rate During the ST + LT Period</title>
        <time_frame>Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Heart Rate During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=182, 181, 176, 170)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.7"/>
                    <measurement group_id="O2" value="1.0" spread="0.7"/>
                    <measurement group_id="O3" value="-0.4" spread="0.8"/>
                    <measurement group_id="O4" value="0.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=178, 179, 175, 164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.8"/>
                    <measurement group_id="O2" value="1.3" spread="0.6"/>
                    <measurement group_id="O3" value="-0.0" spread="0.7"/>
                    <measurement group_id="O4" value="0.1" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=178, 176, 171, 162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.7"/>
                    <measurement group_id="O2" value="1.0" spread="0.6"/>
                    <measurement group_id="O3" value="-0.2" spread="0.7"/>
                    <measurement group_id="O4" value="-0.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=175, 176, 170, 152)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.7"/>
                    <measurement group_id="O2" value="0.8" spread="0.6"/>
                    <measurement group_id="O3" value="0.6" spread="0.7"/>
                    <measurement group_id="O4" value="-0.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=116, 106, 100, 101)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="0.8"/>
                    <measurement group_id="O2" value="0.9" spread="0.8"/>
                    <measurement group_id="O3" value="0.2" spread="1.0"/>
                    <measurement group_id="O4" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=170, 166, 161, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.7"/>
                    <measurement group_id="O2" value="0.7" spread="0.6"/>
                    <measurement group_id="O3" value="0.1" spread="0.7"/>
                    <measurement group_id="O4" value="-1.5" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=132, 129, 124, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.8"/>
                    <measurement group_id="O2" value="1.4" spread="0.8"/>
                    <measurement group_id="O3" value="1.0" spread="0.9"/>
                    <measurement group_id="O4" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=166, 164, 156, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.7"/>
                    <measurement group_id="O2" value="0.4" spread="0.7"/>
                    <measurement group_id="O3" value="-0.5" spread="0.8"/>
                    <measurement group_id="O4" value="-0.5" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=144, 141, 132, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="0.8"/>
                    <measurement group_id="O2" value="1.6" spread="0.8"/>
                    <measurement group_id="O3" value="0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-0.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=163, 155, 153, 147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="0.7"/>
                    <measurement group_id="O2" value="0.9" spread="0.7"/>
                    <measurement group_id="O3" value="-0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-0.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=146, 140, 136, 126)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.9"/>
                    <measurement group_id="O2" value="2.4" spread="0.8"/>
                    <measurement group_id="O3" value="0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-1.6" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=165, 160, 161, 140)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.8"/>
                    <measurement group_id="O2" value="0.2" spread="0.7"/>
                    <measurement group_id="O3" value="0.4" spread="0.7"/>
                    <measurement group_id="O4" value="-0.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=162, 156, 154, 138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.8"/>
                    <measurement group_id="O2" value="0.5" spread="0.7"/>
                    <measurement group_id="O3" value="-0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-0.1" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=154, 151, 149, 123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="0.6" spread="0.7"/>
                    <measurement group_id="O3" value="-0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-0.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=154, 147, 151, 130)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="0.8"/>
                    <measurement group_id="O2" value="0.8" spread="0.8"/>
                    <measurement group_id="O3" value="0.1" spread="0.8"/>
                    <measurement group_id="O4" value="-1.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=151, 138, 145, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.8"/>
                    <measurement group_id="O2" value="0.4" spread="0.8"/>
                    <measurement group_id="O3" value="-0.8" spread="0.7"/>
                    <measurement group_id="O4" value="-0.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=134, 126, 133, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.8"/>
                    <measurement group_id="O2" value="-0.0" spread="0.9"/>
                    <measurement group_id="O3" value="-0.5" spread="0.9"/>
                    <measurement group_id="O4" value="-1.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=124, 116, 125, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.8"/>
                    <measurement group_id="O2" value="-0.3" spread="0.9"/>
                    <measurement group_id="O3" value="-0.2" spread="0.8"/>
                    <measurement group_id="O4" value="-1.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=111, 107, 113, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.9"/>
                    <measurement group_id="O2" value="0.5" spread="0.9"/>
                    <measurement group_id="O3" value="0.6" spread="0.8"/>
                    <measurement group_id="O4" value="-1.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=100, 94, 98, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="0.9"/>
                    <measurement group_id="O2" value="-0.3" spread="1.1"/>
                    <measurement group_id="O3" value="-0.8" spread="1.0"/>
                    <measurement group_id="O4" value="-2.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=94, 88, 90, 52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.9"/>
                    <measurement group_id="O2" value="-0.7" spread="1.2"/>
                    <measurement group_id="O3" value="-0.9" spread="1.1"/>
                    <measurement group_id="O4" value="-0.9" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=87, 82, 85, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="1.0"/>
                    <measurement group_id="O2" value="-1.7" spread="1.2"/>
                    <measurement group_id="O3" value="-0.6" spread="1.2"/>
                    <measurement group_id="O4" value="-1.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=84, 75, 79, 45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="0.9"/>
                    <measurement group_id="O2" value="-0.9" spread="1.4"/>
                    <measurement group_id="O3" value="-0.0" spread="1.2"/>
                    <measurement group_id="O4" value="-2.8" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=78, 67, 75, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1.0"/>
                    <measurement group_id="O2" value="-0.0" spread="1.3"/>
                    <measurement group_id="O3" value="-1.2" spread="1.2"/>
                    <measurement group_id="O4" value="-0.9" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=71, 63, 74, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.1"/>
                    <measurement group_id="O2" value="-2.8" spread="1.3"/>
                    <measurement group_id="O3" value="0.2" spread="1.6"/>
                    <measurement group_id="O4" value="-2.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=70, 60, 72, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.1"/>
                    <measurement group_id="O2" value="-2.2" spread="1.3"/>
                    <measurement group_id="O3" value="-1.1" spread="1.1"/>
                    <measurement group_id="O4" value="-1.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=61, 53, 64, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.2"/>
                    <measurement group_id="O2" value="-0.9" spread="1.2"/>
                    <measurement group_id="O3" value="-1.2" spread="1.2"/>
                    <measurement group_id="O4" value="-1.1" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</title>
        <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
        <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206,</time_frame>
        <population>Number of Participants Analyzed=Treated Participants; BL n=normal or abnormal ECG status at baseline of the cohort of participants with measure at given time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</title>
          <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
          <population>Number of Participants Analyzed=Treated Participants; BL n=normal or abnormal ECG status at baseline of the cohort of participants with measure at given time point</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal BL, Normal Week 12(BL n=108, 109, 104, 104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="98"/>
                    <measurement group_id="O3" value="94"/>
                    <measurement group_id="O4" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 12 (BL n=108,109,104,104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 12 (BL n=69, 66, 70, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 12(BL n=69, 66, 70, 58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 24 (BL n=96, 87, 83, 77)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="79"/>
                    <measurement group_id="O3" value="70"/>
                    <measurement group_id="O4" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 24 (BL n=96, 87, 83, 77)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 24 (BL n=58, 58, 56, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 24(BL n=58, 58, 56, 41)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 76 (BL n=94, 89, 92, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="74"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 76 (BL n=94, 89, 92, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 76 (BL n=51, 52, 59, 44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 76 (BL n=51,52,59,44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 102 (BL n=80, 66, 65, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 102 (BL n=80, 66, 65, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 102 (BL n=43,45,49, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 102 (BL n=43,45,49, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 154 (BL n=60, 46, 53, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 154 (BL n=60, 46, 53, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 154 (BL n=26, 34, 34, 16)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 154 (BL n=26,34,34,16)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 206 (BL n=48, 31, 42, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 206 (BL n=48, 31, 42, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 206 (BL n=20, 25, 28, 13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 206 (BL n=20,25,28,13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>All Reported Hypoglycemic Adverse Events During the ST + LT Treatment Period</title>
        <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>All Reported Hypoglycemic Adverse Events During the ST + LT Treatment Period</title>
          <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Confirmed Hypoglycemia During the ST + LT Treatment Period</title>
        <description>'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg + Metformin</title>
            <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg + Metformin</title>
            <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg + Metformin</title>
            <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo+ Metformin</title>
            <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Confirmed Hypoglycemia During the ST + LT Treatment Period</title>
          <description>'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms.</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="191"/>
                <count group_id="O3" value="181"/>
                <count group_id="O4" value="179"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo+ Metformin</title>
          <description>Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="E2">
          <title>Saxagliptin 10 mg + Metformin</title>
          <description>Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="E3">
          <title>Saxagliptin 2.5 mg + Metformin</title>
          <description>Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
        <group group_id="E4">
          <title>Saxagliptin 5 mg + Metformin</title>
          <description>Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY INSUFFICIENCY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>FOOD POISONING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ABDOMINAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>STOMACH GRANULOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PELVIC MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>BILIARY COLIC</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>SARCOIDOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DRUG HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ERYSIPELAS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BREAST ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SCROTAL ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SINUSITIS BACTERIAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PERIUMBILICAL ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MENINGITIS TUBERCULOUS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>APPENDICITIS PERFORATED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE COLITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>LIMB INJURY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ANKLE FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SKIN LACERATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>INCISIONAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>UPPER LIMB FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>EXOSTOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>RHEUMATOID ARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC PROTRUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>NEURILEMMOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>UTERINE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MULTIPLE MYELOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>NON-HODGKIN'S LYMPHOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BREAST CANCER RECURRENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SOMNOLENCE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ALTERED STATE OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MAJOR DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PSYCHIATRIC SYMPTOM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CALCULUS URINARY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>CALCULUS URETERIC</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>CYSTOCELE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>RECTOCELE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PROSTATITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DYSFUNCTIONAL UTERINE BLEEDING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>STERILISATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>VARICOSE VEIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="129" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="133" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="139" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="133" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>TOOTHACHE</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="191"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="181"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="191"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Boaz Hirschberg</name_or_title>
      <organization>AstraZeneca Pharmaceuticals</organization>
      <email>ClinicalTrialTransparency@astrazeneca.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

